Clinical trials published in high-profile medical journals rarely report on income or other key sociodemographic characteristics of study participants, according to a new study that suggests these gaps may create […]
The moral argument is self-evident and powerful, but improving diversity in the clinical trial patient population and workforce is also the right thing to do from a scientific perspective, says […]
“Whatever we could do to make it easier for patients, we tried to do,” Patrick Floody, senior director of global study strategy and optimization at Regeneron, told attendees of the […]
Institutions and their investors appear to be banking on continued growth in clinical research—in particular, in terms of decentralized clinical trials (DCTs)—being a healthy trend, if recent announcements of significant […]
Nearly half (44%) of recently surveyed pharmaceutical, biotechnology, and clinical research professionals have already adopted remote patient monitoring (RPM) for decentralized clinical trials (DCTs) or have plans to within the […]